Good post. Of course the singles and doubles will help the PPS in the meantime when they launch, to get us to the $1+ range we will need the abuse line up and running or even a partnership to get us there. We all understand this.
Please look at this way. The billions was spoke in terms of pipeline where both opioid and none opioid products are included. To that extend the unbelievability of the claim detachs from the value of non opioid products and especially where not one opioid product appears ready for approval. Why claim billions where the first dollar is far off?
Market Data 
Markets 
AI
